GlassScriptPhysician profile
Johnny Lee Hedges
NPI 1811606858
$1,680.63
in general payments reported to CMS, 2019-2025
14 companies · $516 in 2025
The $516 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $308 · 2024: $857 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,680.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $680.17 | 2023-2025 | Farxiga, Wainua, Lokelma |
| Novartis Pharmaceuticals Corporation | $381.28 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $143.07 | 2023-2024 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $77.63 | 2024-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $75.36 | 2024 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Cvrx, INC. | $67.50 | 2025 | Barostim Neo System |
| Kiniksa Pharmaceuticals International, Plc | $53.43 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.10 | 2025 | Jardiance |
| Novo Nordisk INC | $38.24 | 2024-2025 | Wegovy |
| Pfizer INC. | $32.82 | 2025 | |
| Scpharmaceuticals INC. | $26.39 | 2025 | |
| Vital Connect, INC | $26.18 | 2023 | Vitalpatch Rtm |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.59 | 2024 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $15.87 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnny Hedges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.